Core Insights - U.S. stock futures are trading higher, indicating potential investor interest in several stocks today [1] Company Summaries - **Bank of America Corp. (NYSE:BAC)**: Expected to report quarterly earnings of 95 cents per share on revenue of $27.50 billion. Shares gained 0.3% to $50.22 in after-hours trading [2] - **Papa John's International Inc. (NASDAQ:PZZA)**: Shares rose 14% to $55.50 after Apollo Global Management submitted a new takeover bid at $64 per share [2] - **Morgan Stanley (NYSE:MS)**: Analysts expect quarterly earnings of $2.10 per share on revenue of $16.70 billion. Shares rose 0.8% to $156.59 in after-hours trading [2] - **ASML Holding NV (NASDAQ:ASML)**: Reported third-quarter net bookings of €5.4 billion ($6.27 billion), exceeding expectations. Net sales reached €7.5 billion ($8.71 billion) with a gross margin of 51.6% and net income of €2.1 billion ($2.44 billion). Shares gained 0.2% to $985.00 in after-hours trading [2] - **Abbott Laboratories (NYSE:ABT)**: Expected to report quarterly earnings of $1.30 per share on revenue of $11.40 billion. Shares gained 0.2% to $133.50 in after-hours trading [2]

Core Insights - NextPlat Corp has promoted Amanda L. Ferrio to Chief Financial Officer, succeeding Cecile Munnik, who is leaving the company after a transition period [1][3] Company Overview - NextPlat Corp is a global consumer products and services company that provides healthcare and technology solutions through e-commerce and retail channels [5] - The company aims to assist businesses in optimizing their e-commerce presence and revenue through acquisitions, joint ventures, and collaborations [5] Leadership Transition - Amanda L. Ferrio has over 15 years of accounting and finance experience, previously serving as Vice President of Accounting & Finance at Progressive Care, which was acquired by NextPlat [2][4] - Ferrio's responsibilities at Progressive Care included financial reporting, budgeting, forecasting, and managing SEC filings [2] - The CEO of NextPlat expressed confidence in Ferrio's ability to enhance the company's financial performance and shareholder value [3] Future Contributions - Ferrio expressed gratitude for the opportunity to contribute to NextPlat's transformation and aims to improve operational and financial performance [3]

Core Insights - McKesson Corporation is shifting its business model towards tech-enabled healthcare services to enhance its position in high-margin specialty and digital solutions [1] - Jefferies has set a new price target of $900 for McKesson, indicating a potential increase of 16.96% from its current trading price of $769.49, supported by strategic acquisitions [2][6] - The company's Q1 FY26 results demonstrate strong revenue growth and robust cash flow guidance, leading to raised long-term EPS targets [3][6] Financial Performance - McKesson's current stock price is $769.49, reflecting a 0.78% increase, with a trading range between $752.47 and $775.70 [4] - Over the past year, the stock has fluctuated between a high of $776.14 and a low of $492.39, with a market capitalization of approximately $95.71 billion [4] - Today's trading volume is 513,819 shares, indicating strong investor interest in the company's transformation [5] Strategic Initiatives - Recent acquisitions of PRISM Vision and Core Ventures are aimed at strengthening McKesson's presence in oncology, multispecialty, and technology-enabled segments [2][6] - The ongoing focus on tech-enabled healthcare services is expected to drive further growth and align with Jefferies' optimistic price target [5]

Healthcare Industry Challenges - The current healthcare system often prioritizes efficiency over human connection, leading to patients feeling unseen during consultations, with an average consultation time of approximately 7 minutes [1][2] - Traditional medicine relies on averages, neglecting the unique biological, genomic, lifestyle, and environmental factors of each individual [12][13] Personalized Medicine & Technology - PMX Health utilizes technology to collect and interpret patient health data, identify early risk markers, and provide doctors with a more complete understanding of the patient's story before the consultation begins [6] - Personalized medicine focuses on individual data, health goals, and stories to design customized treatment plans, moving away from a one-size-fits-all approach [13] - Technology can facilitate a healthcare system that benefits both patients and doctors, enabling doctors to practice medicine with a focus on what matters most: patient care and understanding [15][16] Patient Outcomes & Benefits - Personalized medicine leads to improved patient outcomes, including lifestyle and nutrition plans tailored to individual needs, better management of chronic conditions, and early identification of potential health risks [8][9][11] - Patients feel more understood and in control of their health when healthcare is personalized, leading to increased confidence and improved healing [7][10][14][17]

Buffett scoops up these players when he feels they're undervalued and have what it takes to gain the recognition of the rest of the market over time -- then he holds on and generally wins as these companies steadily grow earnings and their businesses. He also is a big fan of dividends and has benefited from owning Dividend Kings like Coca-Cola for decades and collecting passive income.So, first, a quick note on how Buffett goes about investing . He has built an empire as chairman and chief executive officer ...

Market Overview - The U.S. stock market continues to rise, driven by stronger earnings outlooks, with S&P 500 companies expected to report an 8.8% increase in earnings for Q3 year-over-year [2][7] - Recent gains in other assets such as gold, silver, and bitcoin accompany the stock market's performance [6] Economic Indicators - Weak labor market data has raised concerns about economic growth, prompting the Federal Reserve to consider interest rate cuts [6][7] - The ongoing government shutdown, which began on October 1, has disrupted the release of key economic reports, including the monthly employment report and consumer price index [4][5][7] Corporate Earnings - Major banks, including JPMorgan, Goldman Sachs, Wells Fargo, and Citigroup, are set to report quarterly earnings, which will be crucial for assessing the health of the U.S. economy [6][7] - The upcoming earnings season is critical for maintaining market momentum, especially given the high valuations in the stock market [6] Investor Sentiment - Investor optimism is largely based on expected earnings growth, but any signs of weakness could negatively impact market sentiment [4][7] - Attention is focused on whether lawmakers can resolve the government shutdown, as prolonged uncertainty could increase economic risks [4][7]

Group 1 - A securities class action lawsuit has been filed against Molina Healthcare, Inc. on behalf of investors who purchased or acquired Molina securities between February 5, 2025, and July 23, 2025 [1] - The lead plaintiff deadline for the lawsuit is set for December 2, 2025 [1]

Market Performance - Benchmark indices continued to rise, with the Sensex increasing by 394.22 points (0.48%) to 82,566.32 and the Nifty 50 gaining 125.25 points (0.50%) to 25,307.05 as of 12:45 PM [1] - The Nifty Bank index outperformed broader markets, surging 448.10 points (0.80%) to 56,649.40, while the Nifty Financial Services index rose 174.70 points (0.65%) to 26,898.45 [3] Sector Performance - Banking and public sector stocks led the market advance, with State Bank of India rising 1.75% to ₹877.20, Power Grid Corporation gaining 1.42% to ₹290.20, and Adani Ports advancing 1.32% to ₹1,414.00 [2] - Metal stocks faced pressure, with Tata Steel declining 1.54% to ₹173.70, JSW Steel falling 1.25% to ₹1,160.50, and Hindalco dropping 1.16% to ₹765.15 [4] Market Breadth and Investor Activity - Market breadth remained positive, with 2,436 stocks advancing against 1,566 declines on the BSE, and 149 stocks hitting 52-week highs [5] - Foreign institutional investors purchased equities worth ₹1,308 crore, while domestic institutional investors added ₹864 crore, reflecting sustained inflows and optimism regarding India-US trade agreements [6]

Core Viewpoint - Johnson & Johnson will present at the UBS Global Healthcare Conference on November 11th, 2025, indicating the company's ongoing engagement with investors and the healthcare community [1]. Company Presentation Details - Management will participate in a Fireside Chat at 11:00 a.m. Eastern Time, showcasing the company's commitment to transparency and communication with stakeholders [1]. - A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website, allowing broader access to the company's insights and updates [1]. - An archived edition of the session will be available later that day, ensuring that interested parties can review the information at their convenience [1].

As filed with the U.S. Securities and Exchange Commission on October 8, 2025. Registration No. 333-_______ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________ FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ____________________ Soren Acquisition Corp. (Exact name of registrant as specified in its charter) ____________________ Cayman Islands 6770 98-1882094 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Cla ...